secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alto Neuroscience, Inc. (ANRO)
CIK:        0001999480
Form:       8-K
Filed at:   2026-05-13T20:21:06+00:00
Accession:  0001999480-26-000014
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alto Neuroscience annual meeting: ESPP amendment approved, equity plan amendment fails
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2024 ESPP to treat pre-funded warrants as shares for evergreen feature.
- Stockholders rejected amendment to 2024 Equity Incentive Plan to treat pre-funded warrants for share reserve calculation.
- Directors Raymond Sanchez and Gwill York elected; 10.8M votes withheld for York.
- Ratification of Deloitte & Touche LLP as independent auditor for FY 2026 approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1999480/000199948026000014/0001999480-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1999480/000199948026000014/alto-20260512.htm
  HTML page:      https://secwatch.observer/filing/0001999480-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer